When stratified by tumor stage, we found that genes mutated in the IGF2/PI3K pathway occurred more frequently in stages 2 and 3 compared to stage 1 tumors (OR = 1.48, p-value 7.0 × 10−3; Supplementary Data 4). Here, IGF2 is linked to neoplasm.